Ultime notizie per AptarGroup (NYSE:ATR) Azioni

AptarGroup

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

AptarGroup Inc

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics Inc

AtriCure Inc

Atrion Corp

Atari Token

Astronics Corp

Altarea SCA

ALTIUS RENEWABLE ROYALTIS by Altius Renewable Royalties Corp.

Altius Renewable Royalties Corp

ADHERA THERAPEUTICS INC by Adhera Therapeutics Inc.

Adhera Therapeutics Inc

<p>Baird  analyst Ghansham Panjabi   maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Outperform and raises the price target from $170 to $185.</p>


News

Price Target

Analyst Ratings

Baird Maintains Outperform on AptarGroup, Raises Price Target to $185

<p><strong>Share Repurchase Authorization and Cash Dividend</strong></p>
<p>As previously reported, Aptar's Board of Directors authorized the repurchase of $500 million of the Company's common stock. This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. The Board also approved the quarterly cash dividend of $0.45 per share. The payment date is November 14, 2024, to stockholders of record as of October 24, 2024. During the third quarter, Aptar repurchased 95 thousand shares for approximately $14 million.</p>


Buybacks

Aptar's Board Of Directors Authorized The Repurchase Of $500M Of Common Stock; This New Authorization Replaces All Previous Authorizations

<p>Aptar currently expects earnings per share for the fourth quarter of 2024, excluding any restructuring expenses, changes in the fair value of equity investments and acquisition costs, to be in the range of $1.22 to $1.30. This guidance is based on an effective tax rate range of 20% to 22% with a comparable adjusted prior year effective tax rate of 24%. The earnings per share guidance range is based on spot rates at the end of September for all currencies. Based on the fourth quarter guidance, full year adjusted EPS would be in the range of $5.34 to $5.42, a double-digit increase over full year 2023.</p>


Guidance

AptarGroup Sees Q4 EPS $1.22-$1.30 Vs $1.31 Est.; FY24 EPS $5.34-$5.42 Vs $5.36 Est.

<p>AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.42 by 4.93 percent. This is a 6.43 percent increase over earnings of $1.40 per share from the same period last year.  The company reported quarterly sales of $909.29 million which missed the analyst consensus estimate of $922.32 million by 1.41 percent.  This is a 1.82 percent increase over sales of $893.00 million the same period last year.</p>


Earnings

Earnings Beats

Earnings Misses

AptarGroup Q3 Adj $1.49 Beats $1.42 Estimate, Sales $909.29M Miss $922.32M Estimate

<p>For the military, ActivShield&trade; can help wounded service members, particularly those in far-forward environments, have access to sterilized instruments during critical pre-hospitalization periods, following severe injuries.</p>


Contracts

AptarGroup Bags $4.8M, 5-Year Contract From US Federal Government To Advance Development Of Its ActivShield Technology

<p>Wells Fargo  analyst Gabe Hajde   maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Overweight and raises the price target from $168 to $185.</p>


Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $185

WIIM

AptarGroup shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $155 to $215.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/63c6ba8b5750940001b7cb04/jake-roberge">William Blair analyst Jake Roberge</a> upgraded the rating for <strong>Elastic N.V.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) from Market Perform to Outperform. Elastic shares gained 1.2% to close at $83.00 on Friday. <a href="https://www.benzinga.com/quote/ESTC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Rob Owens upgraded <strong>SentinelOne, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) from Neutral to Overweight and raises the price target from $25 to $32. SentinelOne shares fell 0.5% to close at $25.71 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Daniel Rizzo upgraded <strong>AptarGroup, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) from Hold to Buy and raised the price target from $155 to $215. AptarGroup shares gained 1.5% to close at $161.55 on Friday. <a href="https://www.benzinga.com/quote/ATR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Chris McNally upgraded the rating for <strong>BorgWarner Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) from In-Line to Outperform and boosted the price target from $39 to $43. BorgWarner shares gained 0.5% to close at $35.05 on Friday. <a href="https://www.benzinga.com/quote/BWA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Peter Abramowitz upgraded <strong>Easterly Government Properties, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) from Hold to Buy and raised the price target from $13 to $15. Easterly Government Properties shares gained 0.8% to close at $13.27 on Friday. <a href="https://www.benzinga.com/quote/DEA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying ESTC stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14090802/image-98-1024x500.png" alt="" class="wp-image-593848" style="width:541px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14090802/image-98-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14090802/image-98-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14090802/image-98-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14090802/image-98.png 1361w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/10/41308141/this-analyst-with-85-accuracy-rate-sees-around-20-upside-in-amd-here-are-5-stock-picks-for-last-week">This Analyst With 85% Accuracy Rate Sees Around 20% Upside In AMD &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></strong></li>
</ul>


Upgrades

Pre-Market Outlook

Markets

Trading Ideas

ESTC

This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

<p>Jefferies  analyst Daniel Rizzo   upgrades AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) from Hold to Buy and raises the price target from $155 to $215.</p>


Jefferies Upgrades AptarGroup to Buy, Raises Price Target to $215

<p>This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.</p>
<p>The Board also declared a quarterly cash dividend of&nbsp;$0.45&nbsp;per share. The payment date is November 14, 2024, to stockholders of record as of October 24, 2024.</p>


Dividends

AptarGroup Plans Repurchase Of Up To $500M Of Common Stock

<p>N-Sorb leverages company&#39;s proven 3-Phase Activ-Polymer&nbsp;platform technology to address recent concerns related to N-nitrosamine impurities in pharmaceuticals.</p>


AptarGroup Says N-Sorb Nitrosamine Mitigation Solution Has Been Accepted Into FDA Emerging Technology Program

<p><strong>AptarGroup's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has fallen 6.9% since its last report. The company recently reported that it has <strong>474 thousand shares sold short</strong>, which is 0.81% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.03 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726254023_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for AptarGroup has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 3.57%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

How Is The Market Feeling About AptarGroup?

AptarGroup Says Unidose Is The Delivery System Approved With Neffy (Epinephrine Nasal Spray), The First And Only Needle-Free Treatment Approved By FDA For Emergency Treatment Of Patients With Allergic Reactions (Type I)

<p><strong>Enersys </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ens#NYSE">ENS</a>) reported first-quarter fiscal 2025 (ended Jun 30, 2024) adjusted earnings of $1.98 per share, which surpassed the Zacks Consensus Estimate of $1.97. The bottom line increased 5% year over year due to lower operating expenses.</p>
<p>Enersys&#39; net sales of $852.9 million missed the consensus estimate of $878 million. The top line declined 6% year over year due to temporary spending pauses in telecom and broadband. While organic sales decreased 3%, price/mix and foreign currency translation had adverse impacts of 2% and 1%, respectively, on sales.</p>
<h3>Segmental Discussion</h3>
<p>The Energy Systems segment&#39;s sales (accounting for 42.3% of total sales) were $361 million, down 15% year over year. The Zacks Consensus Estimate for segmental net sales was $372 million.&nbsp; Net sales decreased due to capital spending pauses of telecommunication and broadband customers. While organic sales decreased 11%, price/mix and foreign currency translation had an adverse impacts of 3% and 1%, respectively, on sales.</p>
<p>The Motive Power segment generated net sales of $366.2 million (accounting for 43% of total sales), up 4% year over year. The consensus estimate for segmental net sales was $366 million. The upside was driven by a 6% increase in organic volume, partially offset by a 1% unfavorable impact each from price/mix and foreign currency translation.</p>
<p>The Specialty segment&#39;s sales were $125.7 million (accounting for 14.7% of total sales), down 6% year over year. The consensus estimate was $136 million. Organic volume declined 3% and foreign currency translation had an adverse impact of 3% on sales.</p>
<div class="chart_embed">
<h3>Enersys Price, Consensus and EPS Surprise</h3>
<p><img alt="Enersys Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/e2/1723210386.png" style="height:265px; width:576px" title="" /></p>
<p>Enersys price-consensus-eps-surprise-chart | Enersys Quote</p>
</div>
<h3>Margin Profile</h3>
<p>EnerSys&#39; cost of sales decreased 8.8% year over year to $535.8 million. Gross profit decreased 0.8% year over year to $238.4 million while the adjusted gross margin was up 120 basis points (bps) to 28%.</p>
<p>Operating expenses decreased 2.4% year over year to $141.1 million. Adjusted operating earnings were down 1.4% to $106 million. The adjusted operating margin increased 60 bps year over year to 12.4%.</p>
<h3>Balance Sheet and Cash Flow</h3>
<p>At the end of the fiscal first quarter, EnerSys had cash and cash equivalents of $344.1 million compared with $346.7 million at the end of fiscal 2023. Long-term debt (net of unamortized debt issuance costs) was $867.1 million compared with $1.04 billion at the fiscal 2023-end.</p>
<p>EnerSys generated net cash of $10.4 million from operating activities in the fiscal first quarter compared with $74.9 million in the year-ago period. Capital expenditure totaled $36.1 million compared with $16.1 million in the previous year&#39;s period.</p>
<p>In fiscal 2024, EnerSys rewarded its shareholders with a dividend payout of approximately $9.1 million, up 26.1% year over year. Concurrent with the earnings release, the company&#39;s board of directors approved a 7% increase in its quarterly cash dividend, which increased to 24 cents from 22.5 cents per share.</p>
<h3>Guidance</h3>
<p>For fiscal 2025, EnerSys expects adjusted earnings to be in the range of $8.80&ndash;$9.20 per share compared with $8.55&ndash;$8.95 guided earlier. Net sales are now expected to be in the band of $3.735&ndash;$3.885 billion, higher than the previous projection of $3.7-$3.8 billion. The company expects capital expenditures to be approximately $100-$120 million. Tax rate is estimated to be in the band of 20&ndash;21%.</p>
<p>For the fiscal second quarter, the company anticipates adjusted earnings of $2.05&ndash;$2.15 per share. Net sales are projected to be in the range of $880&ndash;$920 million.</p>
<h3>Zacks Rank and Key Picks</h3>
<p>ENS currently carries a Zacks Rank #3 (Hold).</p>
<p>Here are some better-ranked stocks from the same space:</p>
<p><strong>Allegion plc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alle#NYSE">ALLE</a>) presently carries a Zacks Rank #2 (Buy).</p>
<p>It has a trailing four-quarter average earnings surprise of 10.3%.</p>
<p>The Zacks Consensus Estimate for ALLE&#39;s 2024 earnings has increased 1.1% in the past 60 days.</p>
<p><strong>Flowserve Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fls#NYSE">FLS</a>) currently carries a Zacks Rank of 2. FLS delivered a trailing four-quarter average earnings surprise of 18.2%.</p>
<p>In the past 60 days, the consensus estimate for Flowserve&#39;s 2024 earnings has increased 3%.</p>
<p><strong>AptarGroup, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atr#NYSE">ATR</a>) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 7.2%.</p>
<p>In the past 60 days, the Zacks Consensus Estimate for ATR&#39;s 2024 earnings has remained stable.</p>
<p><a href="https://www.zacks.com/stock/news/2320240/enersys-ens-q1-earnings-surpass-estimates-sales-miss?cid=CS-BENZ-FT-analyst_blog|earnings_article-2320240">To read this article on Zacks.com click here.</a></p>


Mid Cap

ALLE

Enersys Q1 Earnings Surpass Estimates, Sales Miss

<p><strong>AptarGroup, Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atr#NYSE">ATR</a>) reported second-quarter 2024 adjusted earnings per share of $1.37, beating the Zacks Consensus Estimate of $1.36. The bottom line increased 12% year over year from $1.22 (including comparable exchange rates).</p>
<p>On a reported basis, earnings per share were $1.34 compared with the year-ago quarter&#39;s $1.24.</p>
<p>Total revenues increased 1.6% year over year to $910 million in the reported quarter. The reported figure missed the Zacks Consensus Estimate of $923 million. Core sales, excluding currency and acquisition effects, improved 3% year over year. The upside was driven by the solid performance in the Pharma segment. We expected core sales to be up 2.6% in the quarter.</p>
<div class="chart_embed">
<h3>AptarGroup, Inc. Price, Consensus and EPS Surprise</h3>
<h3><img alt="AptarGroup, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/a2/1722004605.png" style="height:281px; width:620px" title="" /></h3>
<p>AptarGroup, Inc. price-consensus-eps-surprise-chart | AptarGroup, Inc. Quote</p>
</div>
<h3>Operational Update</h3>
<p>Cost of sales fell 1.1% year over year to $567 million. Gross profit improved 6.3% year over year to $343 million. The gross margin expanded to 37.6% in the reported quarter compared with the prior-year quarter&#39;s 36%.</p>
<p>Selling, research, development and administrative expenses increased 5.76% year over year to $149 million. Adjusted operating income increased 7.54% year over year to $128 million. The adjusted operating margin was 14% in the reported quarter, up from the year-ago quarter&#39;s 13.3%. Adjusted EBITDA rose 6.5% year over year to $193 million in the second quarter.</p>
<h3>Segmental Performances</h3>
<p>Total revenues in the Pharma segment increased 6.1% year over year to $415 million. The reported figure surpassed our estimate of $410 million. Adjusted operating income in the quarter rose 13.5% year over year to $112 million. We predicted a quarterly adjusted operating income of $108 million.</p>
<p>Total revenues in the Beauty segment decreased 2.5% year over year to $321 322 million. Our estimate for the segment&#39;s revenues was $335 million. Operating income improved 8.62% year over year to $24 million in the second quarter. The reported figure surpassed our estimate of operating income of $23 million.</p>
<p>Total revenues in the Closures segment decreased 0.9% year over year to $174 million. We estimated revenues to be $180 million in the quarter. Operating income was $13 million in second-quarter 2023, reflecting a fall of 12.3% from the year-ago quarter. Our prediction for the quarter was $15 million.</p>
<h3>Financial Performance</h3>
<p>ATR reported cash and cash equivalents of $221 million as of Jun 30, 2024, down from $224 million as of Dec 31, 2023. The company generated $144 million of cash flow from operations in the second quarter of 2023 2024 compared with $84 million in the prior-year quarter.</p>
<h3>Outlook</h3>
<p>AptarGroup estimates third-quarter 2024 adjusted earnings per share of $1.38-$1.46.</p>
<h3>Price Performance</h3>
<p>ATR shares have gained 19.5% in the past year compared with the industry&#39;s growth of 9.4%.</p>
<p><img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/00/72601.jpg?v=1979531236" /></p>
<p>Image Source: Zacks Investment Research</p>
<h3>Zacks Rank</h3>
<p>AptarGroup currently has a Zacks Rank #3 (Hold).</p>
<h3>Peer Q2 Performance</h3>
<p><strong>Greif, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gef#NYSE">GEF</a>) reported adjusted earnings per share of 82 cents in second-quarter fiscal 2024 (ended Apr 30, 2024), which surpassed the Zacks Consensus Estimate of 77 cents. The bottom line fell 54% year over year. Results were impacted by elevated raw material, transportation and manufacturing costs, and higher SG&amp;A expenses, reflecting increased compensation expenses and costs incurred for strategic investments.</p>
<p>Sales rose 4.1% year over year to $1.37 billion. The top line surpassed the Zacks Consensus Estimate of $1.31 billion.</p>
<p><strong>Packaging Corporation of America</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pkg#NYSE">PKG</a>) reported adjusted earnings per share of $2.20 in the second quarter of 2024, beating the Zacks Consensus Estimate of $2.12. The reported figure was higher than the company&#39;s guidance of $2.07 in the quarter under review. However, the bottom line decreased 5% year over year.</p>
<p>Sales in the second quarter grew 6.3% year over year to $2.08 billion. The top line beat the Zacks Consensus Estimate of $2.03 billion.</p>
<h3>Packaging Stock Awaiting Results</h3>
<p><strong>Sealed Air Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/see#NYSE">SEE</a>), scheduled to release second-quarter 2024 results on Aug 8, has a trailing four-quarter average surprise of 32.3%. The Zacks Consensus Estimate for SEE&#39;s second-quarter 2024 earnings is pegged at 64 cents per share, suggesting a year-over-year fall of 20%.</p>
<p>The Zacks Consensus Estimate for the company&#39;s top line is pegged at $1.31 billion, indicating a decrease of 5.3% from the prior-year reported figure.</p>
<p><a href="https://www.zacks.com/stock/news/2310321/aptargroup-atr-earnings-beat-estimates-in-q2-increase-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2310321">To read this article on Zacks.com click here.</a></p>


AptarGroup Earnings Beat Estimates in Q2, Increase Y/Y

<p>Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025, and is expected to join the company early in the&nbsp;fourth quarter&nbsp;of 2024 as CFO designate.</p>


Management

Aptar Says CFO Bob Kuhn Has Decided To Retire At End Of This Year; Names Vanessa Kanu As Next CFO

Aptargroup Increases Q3 Adj. EPS To $1.38 - $1.46; Saw $1.36

<p>AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.36 by 0.74 percent.  The company reported quarterly sales of $910.00 million which missed the analyst consensus estimate of $933.17 million by 2.48 percent.  This is a 1.57 percent increase over sales of $895.91 million the same period last year.</p>


AptarGroup Q2 2024 Adj EPS $1.37 Beats $1.36 Estimate, Sales $910.00M Miss $933.17M Estimate

<p><strong>Crown Holdings, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cck#NYSE">CCK</a>) reported second-quarter 2024 adjusted earnings per share of $1.81, beating the Zacks Consensus Estimate of $1.59. The bottom line exceeded the company&#39;s EPS guidance of $1.55-$1.65. It improved 8% year over year.</p>
<p>Including one-time items, the company reported earnings of $1.45 per share in the quarter under review compared with $1.31 in second-quarter 2023.</p>
<p>Net sales totaled $3.04 billion, down 2.2% from the year-ago quarter. The top line missed the Zacks Consensus Estimate of $3.06 billion. The downside was caused by lower volumes across most businesses and unfavorable foreign currency translation. Higher beverage can shipments in the Americas Beverage segment offset some impacts.</p>
<div class="chart_embed">
<h3>Crown Holdings, Inc. Price, Consensus and EPS Surprise</h3>
<p><img alt="Crown Holdings, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/cf/1721744871.png" style="height:285px; width:620px" title="" /></p>
<p>Crown Holdings, Inc. price-consensus-eps-surprise-chart | Crown Holdings, Inc. Quote</p>
</div>
<h3>Costs &amp; Margins</h3>
<p>The cost of products sold fell 3.4% year over year to $2.38 billion. On a year-over-year basis, gross profit moved up 2.3% to $661 million. The gross margin improved to 21.7% from the year-ago quarter&#39;s 20.8%.</p>
<p>Selling and administrative expenses rose 1.4% year over year to $150 million. Segmental operating income was $437 million compared with the prior-year quarter&#39;s $414 million. The upside was driven by increased global beverage operations.</p>
<h3>Segment Performances</h3>
<p>Net sales in the Americas Beverage segment totaled $1.33 billion, up 2.6% year over year. Segmental operating profit increased 15.2% year over year to $243 million.&nbsp;</p>
<p>The European Beverage segment&#39;s sales rose 5.3% year over year to $560 million. Operating income was $88 million compared with the year-ago quarter&#39;s $69 million.</p>
<p>The Asia-Pacific segment&#39;s revenues totaled $290 million, down 12.7% year over year. Operating profit was $55 million compared with the prior-year quarter&#39;s $38 million.</p>
<p>Revenues in the Transit Packaging segment totaled $550 million compared with the year-ago quarter&#39;s $597 million. Operating profit fell 18% year over year to $73 million.</p>
<h3>Cash Flow &amp; Balance Sheet Updates</h3>
<p>Crown Holdings had cash and cash equivalents of $1.41 billion at the second-quarter 2024 end, up from $0.55 billion at the end of the prior-year quarter. The company generated $343 million of cash in operating activities in the first half of 2024 compared with $293 million in the year-ago comparable period.</p>
<p>Crown Holdings&#39; long-term debt decreased to $5.95 billion as of Jun 30, 2024, from $6.99 billion as of Jun 30, 2023.</p>
<h3>Outlook</h3>
<p>Crown Holdings projects third-quarter 2024 adjusted EPS between $1.75 and $1.85.</p>
<p>Backed by a better-than-expected performance in the first half, the company raised its yearly outlook. It projects full-year adjusted EPS of $6.00-$6.25, up from the prior stated $5.80-$6.20.</p>
<h3>Price Performance</h3>
<p>Crown Holdings&#39; shares have lost 13.4% in the past year compared with the industry&#39;s fall of 1.1%.</p>
<p><img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/24/72225.jpg?v=381257066" /></p>
<p>Image Source: Zacks Investment Research</p>
<h3>Zacks Rank</h3>
<p>Crown Holdings currently carries a Zacks Rank #4 (Sell).</p>
<h3>Containers Stocks Awaiting Results</h3>
<p><strong>Silgan Holdings Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slgn#NYSE">SLGN</a>) is scheduled to release its second-quarter 2024 on Jul 31. The Zacks Consensus Estimate for SLGN&#39;s second-quarter 2024 earnings is pegged at 87 cents per share, suggesting year-over-year growth of 4.8%.</p>
<p>The Zacks Consensus Estimate for the company&#39;s top line is pegged at $1.43 billion, suggesting an increase of 0.3% from the prior-year figure. SLGN has a trailing four-quarter average surprise of 1.1%.</p>
<p><strong>Ball Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ball#NYSE">BALL</a>) is scheduled to release its second-quarter 2024 on Aug 1. The Zacks Consensus Estimate for BALL&#39;s second-quarter 2024 earnings is pegged at 73 cents per share, suggesting year-over-year growth of 19.7%.</p>
<p>The Zacks Consensus Estimate for the company&#39;s top line is pegged at $3.07 billion, suggesting a decline of 13.8% from the prior-year figure. BALL has a trailing four-quarter average surprise of 6.8%.</p>
<p><strong>AptarGroup, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atr#NYSE">ATR</a>)&nbsp;is scheduled to release its second-quarter 2024 on Jul 25. The Zacks Consensus Estimate for AptarGroup&#39;s second-quarter 2024 earnings is pegged at $1.36 per share, suggesting year-over-year growth of 10.6%.</p>
<p>The Zacks Consensus Estimate for the company&#39;s top line is pegged at $925.4 million, suggesting growth of 3.3% from the prior-year figure. ATR has a trailing four-quarter average surprise of 9.3%.</p>
<p><a href="https://www.zacks.com/stock/news/2307208/crown-holdings-cck-beats-on-q2-earnings-raises-24-view?cid=CS-BENZ-FT-analyst_blog|earnings_article-2307208">To read this article on Zacks.com click here.</a></p>


BALL

SLGN

Crown Holdings Beats on Q2 Earnings, Raises '24 View

<p><strong>AptarGroup's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has risen 20.34% since its last report. The company recently reported that it has <strong>414 thousand shares sold short</strong>, which is 0.71% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.46 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721669424_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for AptarGroup has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 3.69%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into AptarGroup's Recent Short Interest

Here are the major earnings after the close today

AptarGroup Non-GAAP EPS of $1.49 beats by $0.07, revenue of $909M misses by $14.86M

Reports Q3 revenue $909.3M, consensus $922.3M. "Aptar delivered another strong quarter driven by our Pharma and Closures segments. We saw increased...

AptarGroup reports Q3 EPS $1.49, consensus $1.42

In a report released today, George Staphos from Bank of America Securities maintained a Buy rating on AptarGroup (ATR – Research Report). The compa...

Bank of America Securities Sticks to Its Buy Rating for AptarGroup (ATR)

Analyst Ghansham Panjabi from Robert W. Baird maintained a Buy rating on AptarGroup (ATR – Research Report) and keeping the price target at $170.00...

AptarGroup's Strong Investment Potential Highlighted by Robust Q3 Performance and Strategic Initiatives

AptarGroup, Inc. 2024 Q3 - Results - Earnings Call Presentation

AptarGroup, Inc. (ATR) Q3 2024 Earnings Conference Call Transcript

Wells Fargo analyst Gabrial Hajde has maintained their bullish stance on ATR stock, giving a Buy rating on October 25. Gabrial Hajde has given his ...

Strong Growth Prospects in AptarGroup's Pharma Segment Drive Buy Rating Amid Volatility in Beauty Sector

Baird raised the firm's price target on AptarGroup (ATR) to $185 from $170 and keeps an Outperform rating on the shares. The firm said AptarGroup i...

AptarGroup price target raised to $185 from $170 at Baird

Mid-cap stocks with 'significant scope' to upside – WF

APPF

BURL

BYON

CACI

CINF

COUR

CRWD

CTRA

DECK

DXCM

ENSG

FERG

GLPI

GWRE

HUBS

KNSL

MDYG

MGRC

MPWR

MUSA

NBIX

PFGC

PSTG

ROST

SPOT

SPSC

SSNC

TRGP

TROX

TXRH

UTHR

VALE

VRSN

ZYXI

Press Releases

Aptar Named One of the World's Most Sustainable Companies 2024 by TIME

Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance

Aptar Reports Second Quarter 2024 Results

Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

Daniel Ackerman Named Aptar's Chief Accounting Officer

Aptar's Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

Aptar's N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA's Emerging Technology Program

Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend

Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices

Comments

AptarGroup

Notizie

Ultime notizie per AptarGroup (NYSE:ATR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO